Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -150.95% is 142% below its 5-year average of -62.32%, near the low end of its 5-year range (-150.95%–-16.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.11% below its 12-month average of -114.27%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -150.95%.
RETURN ON EQUITY (ROE)
-150.95%
RETURN ON EQUITY (ROE) AVG TTM
-114.27%
RETURN ON EQUITY (ROE) AVG 3Y
-83.36%
RETURN ON EQUITY (ROE) AVG 5Y
-62.32%
RETURN ON EQUITY (ROE) AVG 10Y
-92.55%
RETURN ON EQUITY (ROE) AVG 15Y
-91.93%
RETURN ON EQUITY (ROE) AVG 20Y
-91.93%
CURRENT VS TTM AVG
-32.11%
CURRENT VS 3Y AVG
-81.08%
CURRENT VS 5Y AVG
-142.23%
CURRENT VS 10Y AVG
-63.10%
CURRENT VS 15Y AVG
-64.21%
CURRENT VS 20Y AVG
-64.21%
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
-319.26%
vs the sector median at left
Cardiff Oncology, Inc.
Market Cap
$87.86M
Return on Equity (ROE)
-150.95%
TTM Avg
-114.27%
3Y Avg
-83.36%
5Y Avg
-62.32%
Market Cap
$88.21M
Return on Equity (ROE)
2.51%
TTM Avg
-5.84%
3Y Avg
-10.75%
5Y Avg
-7.81%
Market Cap
$86.69M
Return on Equity (ROE)
45.93%
TTM Avg
16.96%
3Y Avg
-19.36%
5Y Avg
-13.87%
Market Cap
$84.75M
Return on Equity (ROE)
-85.65%
TTM Avg
-57.41%
3Y Avg
-45.73%
5Y Avg
-8.61%
Market Cap
$84.70M
Return on Equity (ROE)
N/A
TTM Avg
1.45%
3Y Avg
25.22%
5Y Avg
-14.52%
Market Cap
$91.33M
Return on Equity (ROE)
N/A
TTM Avg
329.82%
3Y Avg
69.21%
5Y Avg
21.28%
Market Cap
$91.68M
Return on Equity (ROE)
-32.15%
TTM Avg
-60.32%
3Y Avg
-93.79%
5Y Avg
-79.41%
Market Cap
$84.00M
Return on Equity (ROE)
-309.44%
TTM Avg
-515.53%
3Y Avg
-464.77%
5Y Avg
-329.14%
Market Cap
$83.96M
Return on Equity (ROE)
-50.80%
TTM Avg
-124.86%
3Y Avg
-88.30%
5Y Avg
-60.21%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | $87.86M | -150.95% | -114.27% | -83.36% | -62.32% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 2.51% | -5.84% | -10.75% | -7.81% |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 45.93% | 16.96% | -19.36% | -13.87% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | -85.65% | -57.41% | -45.73% | -8.61% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | N/A | 1.45% | 25.22% | -14.52% |
| electroCore, Inc. (ECOR)vs › | $91.33M | N/A | 329.82% | 69.21% | 21.28% |
| Equillium, Inc. (EQ)vs › | $91.68M | -32.15% | -60.32% | -93.79% | -79.41% |
| Humacyte, Inc. (HUMA)vs › | $84.00M | -309.44% | -515.53% | -464.77% | -329.14% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | -50.80% | -124.86% | -88.30% | -60.21% |
| Conexeu Sciences Inc. (CNXU)vs › | $83.49M | N/A | N/A | N/A | N/A |
ROE
-151.0%
ROA
-107.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -150.95% |
| 2026-03-31 | -128.96% |
| 2025-12-31 | -101.02% |
| 2025-09-30 | -103.34% |
| 2025-06-30 | -87.05% |
| 2025-03-31 | -68.93% |
| 2024-12-31 | -54.77% |
| 2024-09-30 | -87.02% |
| 2024-06-30 | -77.99% |
| 2024-03-31 | -66.06% |
| 2023-12-31 | -59.42% |
| 2023-09-30 | -52.43% |
| 2023-06-30 | -45.79% |
| 2023-03-31 | -40.34% |
| 2022-12-31 | -36.40% |
| 2022-09-30 | -34.85% |
| 2022-06-30 | -31.37% |
| 2022-03-31 | -26.21% |
| 2021-12-31 | -20.15% |
| 2021-09-30 | -19.05% |
| 2021-06-30 | -16.58% |
| 2021-03-31 | -16.34% |
| 2020-12-31 | -15.07% |
| 2020-09-30 | -50.57% |
| 2020-06-30 | -68.07% |
| 2020-03-31 | -270.18% |
| 2019-12-31 | -224.50% |
| 2019-09-30 | -245.35% |
| 2019-06-30 | -180.36% |
| 2019-03-31 | -160.86% |
| 2018-12-31 | -163.25% |
| 2018-09-30 | -106.39% |
| 2018-06-30 | -88.09% |
| 2018-03-31 | -420.89% |
| 2017-12-31 | -382.84% |
| 2017-09-30 | -782.92% |
| 2017-03-31 | -364.60% |
| 2016-12-31 | -198.32% |
| 2016-09-30 | -142.07% |
| 2016-06-30 | -93.89% |
| 2016-03-31 | -74.25% |
| 2015-12-31 | -56.41% |
| 2015-09-30 | -45.16% |
| 2015-06-30 | -151.29% |
| 2015-03-31 | -77.71% |
| 2014-12-31 | -171.58% |
| 2014-09-30 | -86.38% |
| 2014-06-30 | -55.96% |
| 2014-03-31 | -78.24% |
| 2013-12-31 | -57.92% |
| 2013-09-30 | -80.93% |
| 2013-03-31 | -749.73% |
| 2012-12-31 | -533.21% |
| 2012-09-30 | -130.37% |
| 2012-06-30 | -106.15% |
| 2006-07-31 | -419.44% |
| 2006-04-30 | -410.26% |
| 2005-10-31 | -218.36% |
